European Archives - Page 475 of 900 - European Medical Journal

Continue
10 Mins
12th December 2019

Latest Highlights from Guselkumab in Psoriasis from EADV 2019

Guselkumab was the first monoclonal antibody targeting the p19 subunit of IL-23 (IL-23p19) to be approved for the treatment of psoriasis.
10 Mins
12th December 2019

Management of Moderate-to-Severe Atopic Dermatitis in the Era of Targeted Treatments

Prof Augustin opened the symposium by underlining how the management of patients with moderate-to-severe atopic dermatitis (AD) has become more dynamic…
11 Mins
12th December 2019

Improving Intravenous Immunoglobulin Dosing in Autoimmune Neuropathies

This symposium took place on Monday 24th June 2019, as part of the 2019 Peripheral Nerve Society (PNS) Annual Meeting in Genoa, Italy.
3 Mins
12th December 2019

Anticipate Your Next Move in Chronic Myeloid Leukaemia Patient Management

Treatment decisions in chronic myeloid leukaemia (CML) are complex and require the evaluation of many factors at each stage of therapy…
6 Mins
12th December 2019

Integrating Selective Targeted Monoclonal Antibody Therapies for Improved Outcomes in Uncontrolled Asthma

Atypical production of several Th2 cytokines, including IL-4, IL-5, and IL-13, play a central pathogenic role in multiple atopic conditions.
December 2019

European Medical Journal 4.4 2019

EMJ 4.4 is a celebration of triumphant advancements throughout an outstanding year and our spirited elves have been working hard to ensure the year goes out with a festive bang.
9 Mins
12th December 2019

Editor's Pick: Identifying Shared Features and Addressing Common Challenges in Clinical Trials for Chronic Inflammatory Diseases: An Overview

Chronic inflammatory diseases (CID) encompass a wide range of pathologies affecting different organs or bodily functions…
9 Mins
12th December 2019

Clustering by Health Professionals in Individually Randomised Controlled Trials

Researchers that individually randomised controlled trials (iRCT) assume that the observed outcomes of participants…
9 Mins
12th December 2019

Immunotherapy and Oral Immunotherapy with Omalizumab for Food Allergies

Food allergy is potentially life-threatening and has a major impact on quality of life. Avoidance is currently the only approved therapy, and, although…
4 Mins
12th December 2019

A Case of Lance-Adams Syndrome Post Life-Threatening Bronchial Asthma

Lance-Adams syndrome (LAS) is a rare complication that occurs after successful cardiopulmonary resuscitation, in which myoclonus appears rapidly upon…